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ARTICLE OPEN
Microstream capnography during conscious sedation with
midazolam for oral surgery: a randomised controlled trial
Paul Brady1, Gabriella Iohom2, Ken D O’Halloran3, Christine McCreary1 and Michael Cronin4
OBJECTIVES/AIMS: There has been no dentistry-specific published data supporting the use of monitoring with capnography for
dental sedation. Our aim was to determine if adding capnography to standard monitoring during conscious sedation with
midazolam would decrease the incidence of hypoxaemia.
MATERIALS AND METHODS: A randomised controlled trial was conducted in which all patients (ASA I and II) received standard
monitoring and capnography, but were randomised to whether staff could view the capnography (intervention) or were blinded to
it (control). The primary outcome was the incidence of hypoxaemia (SpO2⩽ 94%).
RESULTS:We enrolled 190 patients, mean age 31 years (range, 14–62 years). There were 93 patients in the capnography group and
97 in the control group. The mean cumulative dose of midazolam titrated was 6.94 mg (s.d., 2.31; range, 3–20 mg). Six (3%) patients,
three in each group, required temporary supplemental oxygen. There was no statistically significant difference between the
capnography and control groups for the incidence of hypoxaemia: 34.4 vs 39.2% (P= 0.4962, OR= 0.81, 95% CI: 0.45–1.47).
CONCLUSIONS: We were unable to confirm an additive role for capnography to prevent hypoxaemia during conscious sedation
with midazolam for patients not routinely administered supplemental oxygen.
BDJOpen (2017) 3, 17019; doi:10.1038/bdjopen.2017.19; published online 13 October 2017
INTRODUCTION
For the routine provision of intravenous conscious (moderate)
sedation, dentists typically use a monotherapy technique consist-
ing of boluses of midazolam titrated to effect.1 Care should be
taken to slowly titrate the drug to the desired end point, as there
can be a wide variation in individual response. Most sedative and
anaesthetic agents suppress respiratory drive; therefore, hypox-
aemia remains the one factor that, if not carefully monitored and
controlled, has the potential to cause serious complications.
Current applicable guidelines recommend clinical and electro-
mechanical monitoring including continuous pulse oximetry.2
In relation to capnography, Standards for Conscious Sedation in
the Provision of Dental Care (2015) states the following:
‘Despite the growing pressure for it to be used universally in the
UK, until results of dentistry-specific research are available, its
routine use for ASA grade 1 and 2 dental patients lacks high level
scientific validation and cannot be recommended’.2
Conversely, in North America and Australia, guidelines
recommend capnography for moderate sedation.3–5 Microstream
capnography, a relatively new technology for carbon dioxide (CO2)
monitoring in exhaled air, is capable of reliably monitoring
respiratory patterns in spontaneously breathing patients.6
A special nasal–oral cannula is used to continuously sample CO2
concentration in exhaled breath. From these measurements, the
device plots an ongoing waveform and automatically calculates
the maximum CO2 concentration in each breath, the end tidal
carbon dioxide (EtCO2).
Previous research and two meta-analyses found that capno-
graphy reduced the incidence of hypoxaemia during procedural
sedation.7–11 On the other hand, recent studies from gynaecolo-
gical and endoscopy settings found capnography monitoring did
not reduce the incidence of hypoxaemia.12,13 Therefore, the
generalisability of published research on this issue is problematic.
The lack of a uniform definition of hypoxaemia makes comparison
across the studies difficult. This variability is further compounded
by differences in patient populations, sedation settings, the use of
supplemental oxygen and type of sedation agents and techni-
ques. The aim of this study is to determine if the addition of
microstream capnography to standard monitoring results in a
decreased incidence of hypoxaemia during conscious sedation.
MATERIALS AND METHODS
Study design and setting
This was a prospective, parallel group, randomised controlled trial on
patients receiving intravenous conscious sedation with midazolam for
minor oral surgery procedures. The trial took place at Cork University
Dental School and Hospital in Ireland between January 2014 and
June 2015.
Population
The study protocol was reviewed and approved by the Clinical Research
Ethics Committee of the Cork teaching hospitals. Demographic details,
including alcohol consumption and smoking, were recorded on the patient
medical questionnaire. We excluded patients with ASA classes III–V, body
mass index 435 kg/m2 and patients who refused or were unable to give
informed consent. Written informed consent was obtained from 190
patients aged between 14 years and 62 years attending for minor oral
surgery procedures ranging from single tooth removal to the surgical
removal of impacted wisdom teeth. The study was conducted in
accordance with the moral, ethical and scientific principles governing
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clinical research in the Declaration of Helsinki (2008) and Good Clinical
Practice. The trial was registered at ClinicalTrials.gov under identifier
NCT01949012.
Study protocol
This study was specifically designed to evaluate the use of capnography
monitoring for the most commonly used intravenous conscious sedation
technique in primary dental care. The sedation team consisted of a dentist
who administered the sedation (sedationist) and carried out the operative
procedure (operator), and a dental nurse. This sedationist-operator model
with a suitably trained dental nurse acting as the second appropriately
trained person is common in dental sedation. The research team consisted
of a research nurse and an independent researcher, both of whom had no
direct involvement with the administration of sedation or the operative
procedure. The researcher had received training on the interpretation of
capnography and his role was to prompt the patient to take breaths in
response to capnography readings only in the capnography group.
The randomisation choice was concealed from the teams until after
enrolment. Randomisation was in blocks of varying length (two, four or
six), generated using SAS version 9.3. Subjects were randomly assigned by
the research nurse via sequentially numbered, sealed, opaque envelopes in
a 1:1 ratio into one of two groups: the control group where the principal
investigator and the treating team were blinded to the capnography
screen, and the capnography (intervention) group where the capnography
screen was viewable by all staff and the principal investigator (Figure 1).
Participants and clinicians were aware of the treatment allocation by the
time sedation was administered. In accordance with recognised guidelines,
all patients were continuously monitored for heart rate, pulse oximetry,
visual signs of breathing and periodic (at 10 min intervals) arterial blood
pressure measurement.1 Midazolam was incrementally titrated at a rate of
1 mg/min to an end point determined by the dentist administering the
sedation. Signs of adequate sedation included slurring of speech and
slowed reaction to commands. All patients in the study had local
anaesthetic (2% lignocaine with adrenaline) administered to provide
analgesia for the procedure.
To enable sampling for microstream capnography, all the patients were
fitted with a specialised nasal cannula oxygen device with a built-in
sampling port (Smart Capnoline plus O2; Covidien Inc., Mansfield, MA)
designed to capture inspired and expired carbon dioxide orally and nasally.
The sampling port is specifically designed to work with standard oxygen
delivery systems to enable the administration of supplemental oxygen
when required. This sampling device was connected to the capnography
monitoring device (Capnostream 20, Covidien, Mansfield, MA), which
displayed real-time CO2 in waveform and numeric form, respiratory rates
and pulse oximetry functions. Supplemental oxygen was not routinely
administered during the sedations. In the capnography group, an
independent research observer monitored the patients for respiratory
activity via the capnography monitor. Any sign of apnoea, altered
ventilation or oxygen desaturation to SpO2⩽ 94% prompted an interven-
tion in a step-wise fashion that included verbal stimulation to take breaths
and, if required, oxygen supplementation. The reversal of sedation with the
benzodiazepine antagonist, flumazenil, was included in the protocol;
however, sedation is not routinely reversed in conscious dental sedation.
Indications for the administration of flumazenil include when safe
saturation levels cannot be maintained and in a medical emergency.
Capnography waveforms on the capnography monitor enable visual
assessment of ventilation. The capnographic criteria for respiratory
depression or airway obstruction included a capnogram depicting alveolar
hypoventilation, a flat waveform (apnoea) or a respiratory rate less than
10 breaths/min.
The capnostream 20 records data electronically every 2 s during the
course of each sedation. Continuous data from the monitor was acquired
on a laptop computer via a communications interface adapter employing
specific oximetry software (Profox Associates inc. USA). This allowed for
post hoc analysis of the monitoring data.
The majority of dental sedation is administered in primary care and the
limitations of this environment must be appreciated.14 Therefore, early
warning of desaturation is essential. The primary outcome variable was any
occurrence of hypoxaemia defined as oxygen saturation (SpO2) ⩽ 94% of
any duration. For the purposes of this study in a dental setting, safe oxygen
saturation levels were defined as 95% and higher. When SpO2 drops to
⩽ 94%, it is a trigger for the sedation team to ask for breaths. The
oxyhaemoglobin desaturation curve is sigmoidal, and desaturation occurs
very rapidly in the apnoeic or airway-obstructed patient once levels of 92%
and lower are reached. The secondary outcome was the degree of
hypoxaemia.
Statistical analysis
The sample size calculation was based on (1) an observation study
investigating capnometry that was performed in a sample of 33 adults in
the same setting at this institution and (2) studies from other settings that
demonstrated levels of hypoxaemia between 17 and 30%.15–17 A sample
size of 95 per group had 80% power at the 5% level of significance to
demonstrate a reduction in proportions of patients experiencing any
hypoxaemia (SpO2⩽ 94%) from 30% in the control group to 15% in the
capnography group. The primary outcome measure of any hypoxaemia
(SpO2⩽ 94%) was compared between the capnography and control
groups using logistic regression comparisons and x2 test of proportions
in SAS (Version 9.4). Analyses were performed on the following secondary
outcome measures: the proportion of patients experiencing moderate
hypoxaemia (defined as 90%⩽ SpO2⩽ 92%) and the proportion of patients
experiencing severe hypoxaemia (defined as SpO2o90%). Interventions to
correct hypoxaemia in response to desaturation were quantified as the
number of patients receiving verbal prompts to take breaths and the
number of patients receiving supplemental oxygen.
RESULTS
We screened 202 patients for possible study participation. Four
refused to wear the oral/nasal cannula prior to the randomisation
envelope being opened; the remaining 198 patients were
randomised to the control or the capnography (intervention)
group. Eight patients were removed during data processing as
more than 20% of their pulse oximetry or capnography data was
missing or incomplete at post hoc analysis. Technical difficulties,
such as recording errors and patient movement, were the most
common reasons for the loss of data. There were 190 patients in
the analysis: 97 in the control group and 93 in the capnography
group (Figure 2).
Outcome measures
For the primary outcome measure, we found no difference in the
proportion of patients who experienced hypoxaemia (SpO2⩽ 94%)
between the capnography and the control group 34.4 vs. 39.2%
(P= 0.4962, OR= 0.81, 95% CI: 0.45–1.47). The number of patients
receiving verbal stimulation to take breaths was higher in the
capnography group than in the control group: 54 vs 38 (Table 1).
The mean cumulative dose of midazolam per patient at end point
was 6.94 mg (s.d., 2.31) and the range of dosage 3–20 mg.
Six (3%) patients, three in each group, required supplemental
oxygen. The mean age of patients requiring supplemental oxygen
was 48.83 years (s.d., 13.89). Their mean cumulative dose of
midazolam at end point was 5.6 mg (s.d., 1.3) and the dosage
range was 4–8 mg.
Figure 1. Vital signs monitor. Control (blinded capnography) and
Capnography (intervention).
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DISCUSSION
We were unable to demonstrate that the addition of capnography
to standard clinical and electromechanical monitoring for
moderately sedated (conscious) patients on room air results in a
decreased incidence of desaturation in an oral surgery setting.
Conversely, a meta-analysis revealed that respiratory depression
was 17.6 times more likely to be detected during procedural
sedation in patients who were monitored with capnography than
with standard monitoring alone.10 Many of the studies in this
meta-analysis were from settings where deep sedation was the
target: supplemental oxygen was routinely administered and
combinations of drugs were used. In the United Kingdom and
Ireland, sedation in the deep end of the sedation continuum is
regarded as general anaesthesia and falls outside the definition of
moderate (conscious) sedation.1 In the present study, we utilised
conscious sedation and patients were not pre-oxygenated with
supplemental oxygen. Our results are in agreement with recently
published data from two clinical trials in endoscopy and
gynaecology settings, which were unable to confirm an additive
role for capnography in preventing hypoxaemia for patients not
receiving routine supplemental oxygen.12,13 Our findings are also
in agreement with a study from an emergency room setting
evaluating whether capnography or pulse oximetry first detected
respiratory events in sedated adults breathing room air.18 They
found pulse oximetry detected hypoxaemia well before capno-
graphic changes were observed. The term procedural sedation
includes moderate and deep sedation on the sedation continuum.
Perhaps, when considering the evidence for capnography
Assessed for eligibility (n = 202) 
Excluded (n = 4) 
♦ Refused to wear the oral/nasal 
sampling device 
Allocated to control (n = 99) 
♦ Monitored using the standard procedure only; 
staff blinded to capnography
Allocated to capnography (n = 99) 
♦Monitored using a combination of standard 
procedure and capnography assessment
Analysed (n = 97) 
Randomized (n = 198)
Analysed (n = 93) 
Lost due to technical failure (n = 6)Lost due to technical failure (n = 2)
Figure 2. CONSORT recrutment diagram.
Table 1. Primary and secondary outcome measures: capnography versus control groups
Capnography (n= 93) Control (n= 97) P-value Odds ratio 95% CI
Primary outcome
Patients with any hypoxaemia 34.4% 39.2% 0.4962 0.814 0.451 1.471
Secondary outcomes
Patients with:
Moderate hypoxaemia 24.7% 23.7% 0.8697 1.057 0.544 2.053
Severe hypoxaemia 11.8% 8.3% 0.4132 1.492 0.572 3.893
Patients receiving:
Verbal stimulation 54 38 0.0139
In response to SpO2 17 38
In response to capnography 37 —
Supplemental O2 3 3 0.8236
Logistic regression comparisons and χ2-test of proportions. Any (SpO2≤ 94%), moderate (90%≤ SpO2≤ 92%) and severe (SpO2o90%) hypoxaemia.
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monitoring, the term procedural sedation is too broad. Certainly,
for deep sedations where supplemental oxygen is required, the
evidence supports capnography monitoring to reduce the
incidence of hypoxaemia.7–11 However, for conscious sedation
where patients breathe room air, it would appear from our
findings and also from other studies that the addition of
capnography does not significantly reduce the incidence of
hypoxaemia.12,13
Our dosage illustrates the wide range when titrating midazolam
to effect in this setting. We chose an oxygen saturation of ⩽ 94%
as the primary outcome measure, in part because it represents a
consensus threshold point in dental sedation units at which staff
acts to stimulate a sedated patient out of concern that the patient
is not adequately ventilating. In the present study, the overall level
of hypoxaemia (SpO2⩽ 94%) was 37%, which is consistent with
the reported incidences in reasonably comparable studies that
demonstrated levels of hypoxaemia between 17 and 47% with
midazolam.17,18 Just 10% of our patients had an SpO2 event
⩽ 90%. An SpO2 of 90% is the recommended setting for alarm
activation on pulse oximeters for dental sedation.
Females are known to be more dentally anxious than males.19 In
the present study, as shown in Table 2, there were over twice as
many females as males enrolled (131 females and 59 males).
In accordance with our institutional policy, patients did not
routinely receive supplemental oxygen unless indicated due to
hypoxaemia. The percentage of patients requiring supplemental
O2 is comparable with a similar previous study in an emergency
room setting.20 Routine supplemental O2 administration is
considered to diminish the value of pulse oximetry as a respiratory
monitor of early respiratory compromise, since hypoxaemia
becomes a late sign of respiratory depression.21 Deitch et al.22
found that supplemental O2 was related to a higher incidence of
respiratory depression. More patients were stimulated to take
breaths in our capnography group than in the control group. It is
likely that many of the capnography changes seen in the present
study were subclinical. Episodes of respiratory depression
occurring during sedation can be transient and not all such
occurrences result in patient harm.9 In this context, it is important
to note that calling for breaths in response to transient respiratory
depression that would have resolved spontaneously without
harming the patient may be counterproductive because it could
result in inadequate sedation.23 Interestingly, Barnett et al.24 found
that patients in their capnography group experienced significantly
more discomfort. They hypothesised that this may relate to
interventions (e.g., airway repositioning) in response to clinically
insignificant EtCO2 waveform changes that result in patients being
more frequently stimulated. None of our patients required reversal
of the sedation with the benzodiazepine antagonist flumazenil
and all patients had their treatment successfully completed.
The results of this study can only be applied to situations where
midazolam is administered as a single drug for conscious sedation
in healthy adults. The importance of patient selection and pre-
sedation assessment cannot be overemphasised to ensure a
healthy cohort of patents for sedation in a dental setting who are
unlikely to require supplemental oxygen. The key principle is that
when supplemental oxygen is provided for any reason, the pulse
oximeter must never be misconstrued as monitoring ventilation.
For patients requiring supplemental oxygen, monitoring with
capnography will provide the clinician with useful additional
information regarding respiratory function. Capnography should
be taught on dental sedation courses and we recommend a move
towards having capnography at hand for situations when
supplemental oxygen is administered. Vital signs monitors with
capnography functionality are becoming more affordable and
clinicians purchasing new monitors should look for this function to
be included. Benzodiazepines may be up to eight times more
potent after prior administration of an opioid and respiratory
depression is more likely to occur when more than one sedative
agent is administered.25,26 With the growing usage of drugs in
combination to deliver dental sedation, there is a need for future
research as respiratory depression is more likely with drugs
in combination than for the monotherapy technique in the
present study.
Limitations
The principal strength of this study is that it was conducted in a
real-world setting albeit that an independent researcher was used
for the capnography interpretation. There are several potential
limitations to our study. First, it is possible that our continuous
electronic data collection influenced the rate of hypoxaemia
because it would detect episodes that might otherwise be missed
through human inattention or error. Second, while obvious
artifacts were eliminated during analysis of the recorded data,
the possibility of residual miscalculation of hypoxaemia due to
artifacts remains. Third, we did not record the depth of sedation
by using a scale, such as the Ramsey scale, or by monitoring with
bispectral index or entropy. We believe that the randomisation
process would have led to equitable distributions of depth of
sedation between the two groups. Thus, recording the depth of
sedation would not have had any significant impact on the overall
study results. Future research should evaluate the impact of
capnography on patient satisfaction during routine oral surgery.
CONCLUSION
This study set out to determine if adding capnography to standard
monitoring during conscious sedation would decrease the
frequency of oxygen desaturation in an oral surgery setting. We
were unable to confirm an additive role for capnography to
prevent hypoxaemia during conscious sedation with midazolam
(monotherapy) in ASA I and II patients not routinely administered
supplemental oxygen. The results of this study provide dentistry-
Table 2. Characteristics of capnography and control arms for enrolled
patients
Characteristic Capnography
(n= 93)
Control
(n= 97)
P value
n (%)
Gender
Male 24 (26%) 35 (36%) 0.13
Female 69 (74%) 62 (64%)
Alcohol drinker 59 (63%) 52 (54%) 0.23
Smoker 24 (26%) 26 (27%) 0.88
ASA classification
I 65 (70%) 61 (63%) 0.31
II 28 (30%) 36 (37%)
Mean (s.d.)
Age (years) 31.2 (12.7) 31.5 (12.4) 0.86
BMI (kg/m2) 24.5 (3.7) 24.4 (4.2) 0.99
Baseline parameters
EtCO2 (mm Hg) 37.6 (3.8) 36.4 (4.1)
Respiratory rate (per min) 17.9 (4.6) 17.3 (4.5)
SpO2 (%) 99.1 (1.2) 99.2 (1.2)
Abbreviations: ASA, American Society of Anesthesiologists; BMI, body
mass index; EtCO2, end-tidal carbon dioxide; SpO2, haemoglobin oxygen
saturation.
Data are presented as mean (s.d.) or n (%) as appropriate.
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specific evidence to support current guidelines with regard to
monitoring with capnography.
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